Aspirin-induced asthma (Q42859): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1030818265 / rank | |||
Normal rank | |||
Revision as of 09:35, 13 August 2026
In some asthma individuals, acetylsalicylic acid (aspirin®™) and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase 1 (COX-1) exacerbate the condition. This distinct clinical syndrome, called aspirin-induced asthma (AIA), is characterised by an eosinophilic rhinosinusitis, nasal polyposis, aspirin hypersensitivity, and asthma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | CA23.20 |
||
| English | Aspirin-induced asthma |
In some asthma individuals, acetylsalicylic acid (aspirin®™) and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase 1 (COX-1) exacerbate the condition. This distinct clinical syndrome, called aspirin-induced asthma (AIA), is characterised by an eosinophilic rhinosinusitis, nasal polyposis, aspirin hypersensitivity, and asthma. |
